Skip to main content

Select Drug Profiles

Perspectives
Still at It
David B. Nash, MD, MBA
David B. Nash, MD, MBA
Read More
Original Research
Predictors of Transitioning to Incident Chronic Opioid Therapy Among Working-Age Adults in the United States
J. Douglas Thornton, PhD, PharmD, BCPS, Nilanjana Dwibedi, BPharm, MBA, PhD, Virginia Scott, PhD, Charles D. Ponte, PharmD, Douglas Ziedonis, MD, Nethra Sambamoorthi, PhD, Usha Sambamoorthi, PhD
J. Douglas Thornton, PharmD, PhD; Nilanjana Dwibedi, PhD; Virginia Scott, PhD; Charles D. Ponte, PharmD; Douglas Ziedonis, MD; Nethra Sambamoorthi, PhD; Usha Sambamoorthi, PhD
Stakeholder Perspective
Addiction Prediction: Preventing Iatrogenic Opioid Dependence
Albert Tzeel, MD, MHSA, CPE, FAAPL
by Albert Tzeel, MD, MHSA, CPE, FAAPL
Read More
Press Releases, Original Research
Researchers Identify 4 Predictors of Transition to Chronic Opioid Use Based on Readily Available Opioid Regimen and Patient Factors
Read More
Practice Management
Healthcare Trends for 2018
F. Randy Vogenberg, PhD, FASHP, John Santilli, MBA
F. Randy Vogenberg, PhD, RPh; John Santilli, MBA
Read More
Press Releases
Access Market Intelligence Introduces Online Glossary of Common Drug Related Terms and Acronyms as e-Book
Read More
A Multistakeholder Consensus on Challenges and Solutions to the Adoption of Biosimilars
Robert M. Rifkin, MD, FACP, Edward Li, PharmD, MPH, BCOP, Gillian Woollett, MA, DPhil
Read More
Perspectives
“Alexa, Refill My Omeprazole”
David B. Nash, MD, MBA
David B. Nash, MD, MBA
Read More
Original Research
Prospective Bundled Payments in a Changing Environment: The Experience of a Self-Funded, State-Sponsored Plan
Frank H. Lawler, MD, MSPH, Frank R. Wilson, CPA, G. Keith Smith, MD, Lynn V. Mitchell, MD, MPH
Frank H. Lawler, MD, MSPH; Frank R. Wilson, CPA; G. Keith Smith, MD; Lynn V. Mitchell, MD, MPH
Stakeholder Perspective
Oklahoma Benefits Program Setting an Example: A Cost-Effective Bundled Payments Option for State Employees
James T. Kenney, RPh, MBA
by James T. Kenney, RPh, MBA
Read More
Original Research, Practice Management
The Effects of a Sitagliptin Formulary Restriction Program on Diabetes Medication Use
Yuexin Tang, PhD, Xingyue Huang, PhD, Jinan Liu, PhD, R. Ravi Shankar, MD, Michael L. Ganz, PhD, Swapnil Rajpathak, MD, DrPH
Yuexin Tang, PhD; Xingyue Huang, PhD; Jinan Liu, PhD; R. Ravi Shankar MD; Michael L. Ganz, PhD; Swapnil Rajpathak, MD, DrPH
Stakeholder Perspective
Impact of Step Therapy Restrictions in Diabetes Care
Quang T. Nguyen, DO, FACP, FACE, FTOS
by Quang T. Nguyen, DO, FACE, FTOS
Read More
Conference Highlights AMCP
AMCP Nexus 2017 Highlights
Read More
Page 76 of 244
Results 751 - 760 of 2438